Vedanta Biosciences, a biotech startup developing a class of drugs that work by modulating the human microbiome, today announced it has been awarded a second research grant from CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), a global non-profit partnership dedicated to […]